Influences of Parameter Uncertainties Within the Icrp-66 Respiratory Tract Model: Particle Clearance

Abstract

Quantifying radiological risk following the inhalation of radioactive aerosols entails not only an assessment of particle deposition within respiratory tract regions but a full accounting of clearance mechanisms whereby particles may be translocated to adjacent respiratory tissue regions, absorbed to blood, or released to the gastrointestinal tract. The model outlined in ICRP Publication 66 represents to date one of the most complete overall descriptions of particle deposition and clearance, as well as localized radiation dosimetry, within the respiratory tract. In this study, a previous review of the ICRP-66 deposition model is extended to the study of the subsequent clearance model. A systematic review of the clearance component within the ICRP 66 respiratory tract model was conducted in which probability density functions were assigned to all input parameters for both 239PuO2 and 238UO2/238U3O8. These distributions were subsequently incorporated within a computer code LUDUC (Lung Dose Uncertainty Code) in which Latin hypercube sampling techniques are used to generate multiple (e.g., 1,000) sets of input vectors (i.e., trials) for all model parameters needed to assess mechanical clearance and particle dissolution/absorption. Integral numbers of nuclear disintegrations, U(s), in various lung regions were shown to be well-described by lognormal probability distributions. Of the four extrathoracic clearance compartments of the respiratory tract, uncertainties in U(s), expressed as the ratio of its 95% to 5% confidence levels, were highest within the LN(ET) tissues for 239PuO2 (ratio of 50 to 130) and within the ET(seq) tissues for 238UO2/238U3O8 (ratio of 12 to 50). Peak uncertainties in U(s) in these respiratory regions occurred at particle sizes of approximately 0.5-0.6 microm where uncertainties in ET2 particle deposition fractions accounted for only approximately 10% of the total U(s) uncertainty for 239PuO2, and only approximately 30% of the total U(s) uncertainty for 238UO2/238U3O8 (the remainder is attributed to the clearance model alone). Of the eight clearance compartments within the thoracic regions of the respiratory tract, and for particle sizes below approximately 5 microm, uncertainties in U(s) were highest within the LN(TH) tissues for 239PuO2 (ratio of 60 to 80) and within the BB(seq) tissues for 238UO2/238U3O8 (ratio of 20 and 60). At particle sizes exceeding approximately 5 microm in aerodynamic diameter, peak uncertainties in U(s) are noted for the AI, bb(seq), and bb1 clearance compartments. As the particle size approaches 10 microm in size, uncertainties in U(s) within these three thoracic tissue regions approach a factor of 1,000 and are dominated by corresponding uncertainties in particle deposition.

Performance Evaluation of an Andersen Cascade Impactor with an Additional Stage for Nanoparticle Sampling

“…Consequently, evaluating the chemical characteristics of these ultrafine nanoparticles is particularly important for an understanding of the impact to general health of airborne particulates that are small enough to enter the human respiratory system. Because a large proportion of nanoparticles penetrate the lung periphery, i.e., the alveolar region, particles deposited in the alveoli are readily transferred to the blood and are then quickly dispersed throughout the human body, including infants (Hinds, 1999;Bolch et al, 2001;Semmler-Behnke et al, 2012). Furthermore, at least one report on the effect that oral exposure to nanoparticles has on the human body, has determined that all kind of nanoparticle behavior in the environment could be issues that should be investigated (Mahler et al, 2012).…”

Indoor ultrafine particle exposures and home heating systems: A cross-sectional survey of Canadian homes during the winter months

“…UFPs are efficiently deposited in the human airway (Wilson et al, 1985;Jaques and Kim, 2000;Kim and Jaques, 2005), with the majority of 20-100 nm particles depositing in the respiratory bronchioles and alveoli (Bolch et al, 2001;Lazardis et al, 2001). People with asthma or chronic obstructive pulmonary disease may be particularly susceptible to the respiratory effects of UFPs, as deposition is greater in these individuals (Brown et al, 2002;Chalupa et al, 2004).…”

Radiation dose assessment of exposure to depleted uranium

“…The U S ratios between our and DCAL results are in the range of 0.995-1.001. Bolch et al (2001Bolch et al ( , 2003 analyzed the influences of uncertainties of particle deposition and clearance parameters on the nuclear transformations in the ICRP HRTM. It is found that in all the regions of the respiratory tract for an adult male at light exertion, uncertainties in particle deposition fractions are distributed only over a range of about a factor of 2-4 for particle sizes between 0.005 and 0.2 mm.…”